Prevenar 13
PCV13 - Pneumococcal Conjugate Vaccine 13-valent
The vaccine provides protection against those 13 serotypes that are most frequently responsible for pneumococcal infections and are known to cause the most severe cases, particularly in infants, the elderly, and immunocompromised individuals.
Prevenar 13 is presented as a sterile injectable suspension, pre-filled in single-use syringes (each containing a 0.5 mL dose) - The preparation is ready for direct intramuscular administration without the need for additional manipulation.
The vaccine contains both active and excipient (inactive) components.